CD274 and neoplasm: The best described acquired resistance mechanisms are the overexpression of alternative ICI such as TIM3 on immune cells or PD-L1 on tumor cells, the dysfunction of the presentation of the antigen by MHC I or the mutations of genes such as JAK1/2 (10–13).